Making Cells Work 2026

Join researchers, clinicians, biotechnology leaders, and industry partners for a FREE one day symposium exploring the latest advances in engineered cell therapies and regenerative medicine.

Pre-Registration Required

Event Details

Date

Tue, Nov 3 2026

Time

7:30am - 4:00pm

Location

McNamara Alumni Center | 200 Oak Street S.E Minneapolis, MN 55455

Speakers

Branden Moriarity

PhD, Professor, Division of Pediatric Hematology/Oncology

Shalmica Jackson

PhD, Associate Director of CGT Market Development at Lonza Biosciences.

Charlie DeLisle

PhD, Sr. Biopharma Account Manager at Waters

Mary Garry

PhD, Professor of Medicine, Cardiovascular Division

Saad Kenderian

M.B., Ch.B., Assistant professor and consultant in the departments of oncology, medicine, immunology, and molecular medicine at Mayo Clinic

Isaac Adjei

PhD, Field Applications Scientist for Cytiva Nanomedicine

PhD, Daryl Gohl

Associate Research Professor Group Leader, UMGC Innovation Lab

John Garbe

Information Technology Professional, Genomics Center

Beau Webber

PhD, Associate Professor, Division of Pediatric Hematology/Oncology

Molly Lynch

Research Professional, Masonic Cancer Center

Elizabeth Hirsch

PharmD, FCCP, FIDSA, FIDP, Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)

Branimir Bugarija

PhD, is the CRISPR Field Application Scientist Manager at Integrated DNA Technologies (IDT)

Walter Low

PhD, Professor, Neurosurgery

Rita Perlingeiro

PhD, Lillehei Professor, Stem Cell and Regenerative Cardiovascular Med

Christine Robinson

Miltenyi Biotec

Rubayat Jamal

PhD, Cell Therapy Application Specialist at Cytiva

Michael Kyba

PhD, Professor, Pediatrics

Andrew Crane

PhD, MS, Assistant Professor, Division of Gastroenterology, Hepatology and Nutrition

Matthias Koenning

PhD, Senior Field Application Scientist

David Largaespada

PhD, Professor, Department of Pediatrics

Agenda

Expand all

Agenda

Making Cells Work: Advancing Engineered Cell Therapies from Discovery to Translation

Participants will discuss:

Cutting-edge research in genetically engineered cell therapies
Emerging sequencing and analytical technologies that enable cell therapy development
Pathways for translating discoveries into IND-ready therapies

Time	Session	Title	Speaker(s)
8:00-8:40 AM	Check-In and Welcome		Branden Moriarity
8:40-8:50 AM	Lonza Biosciences	Non-viral delivery of complex cargos for cell therapy development	Shalmica Jackson
8:50-9:00 AM	Waters	Illuminating Particle Contaminants in Cell Therapy Products	Charlie DeLisle
9:00 - 9:50 AM	Session 1	Regenerative Medicine in Practice	Mary Garry Saad Kenderian
9:50-10:00 AM	Cytiva	Advancing in vivo cell therapy with lipid nanoparticles	Isaac Adjei
10:00 - 10:50 AM	Session 2	Genomic Technologies to Interrogate Cellular Therapeutics	Daryl Gohl John Garbe Beau Webber Molly Lynch Betsy Hirsch
10:50-11:00 AM	Integrated DNA Technologies	From Edited Cells to IND-Ready Data: End-to-End Genotoxicity Assessment for Cell Therapy Development	Branimir Bugarija
11:00-11:50 AM	Session 3	From Discovery to IND	Walt Low Rita Perlingeiro
11:50-12:00 PM	Miltenyi Biotec	Your Partner from Bench To Bedside	Christine Robinson
12:00-12:30 PM	Speed Networking
12:30-12:50 PM	Lunch Break
12:50-1:00 PM	Cytiva	Navigating the complex journey of cell therapy manufacturing from lab to patient	Rubayat Jamal
1:00 - 1:50 PM	Session 4	Building Better Cell Therapies Through Genomics	Michael Kyba Andrew Crane
1:50 - 2:00 PM	Quanterix Spatial (Akoya)	PhenoCycler 2.0 - Next-generation spatial proteomics tools to study immunology, tissue remodeling, and regeneration	Matthias Koenning
2:00 - 2:50 PM	Session 5	The Future of Engineered Cell Therapies	David Largaespada Branden Moriarity
2:50-3:00 PM	GenScript
3:00 - 3:30 PM	Closing		David Largaespada

Making Cells Work 2026

+ Agenda

Agenda